Skip to Main Content

The federal government has now invested about $6 billion in the Covid-19 vaccine from Moderna, the Cambridge, Mass., biotech that few outside the scientific and investment worlds had heard of a couple of years ago.

Moderna said in a filing with the Securities and Exchange Commission on Wednesday that under a change in its government contract on April 18, it will receive as much as $236 million in additional reimbursement for costs associated with its late-stage vaccine trial on about 30,000 volunteers, including safety monitoring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED